- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-octamer
- Ligands
- 16 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.2: 20 residues within 4Å:- Chain A: H.93, T.252, R.253, E.254, D.274, S.275, S.276, Q.277, Y.282, R.322, G.326, C.331, T.333, M.414, Q.441
- Chain B: I.45, A.46, H.466, Q.469
- Ligands: IMP.3
12 PLIP interactions:9 interactions with chain A, 3 interactions with chain B- Hydrogen bonds: A:H.93, A:T.252, A:R.253, A:S.276, A:S.276, A:T.333, B:H.466, B:Q.469, B:Q.469
- Salt bridges: A:R.253
- pi-Stacking: A:Y.282
- pi-Cation interactions: A:R.253
NAD.7: 21 residues within 4Å:- Chain B: H.93, T.252, R.253, E.254, D.274, S.275, S.276, Q.277, Y.282, N.303, R.322, M.325, G.326, T.333, M.414, Q.441
- Chain C: I.45, A.46, H.466, Q.469
- Ligands: IMP.8
12 PLIP interactions:3 interactions with chain C, 9 interactions with chain B- Hydrogen bonds: C:H.466, C:Q.469, C:Q.469, B:H.93, B:T.252, B:R.253, B:S.276, B:S.276, B:T.333
- Salt bridges: B:R.253
- pi-Stacking: B:Y.282
- pi-Cation interactions: B:R.253
NAD.12: 22 residues within 4Å:- Chain C: P.69, H.93, T.252, R.253, E.254, D.274, S.275, S.276, Q.277, Y.282, N.303, R.322, M.325, G.326, T.333, M.414, Q.441
- Chain D: I.45, A.46, H.466, Q.469
- Ligands: IMP.13
12 PLIP interactions:9 interactions with chain C, 3 interactions with chain D- Hydrogen bonds: C:H.93, C:T.252, C:R.253, C:S.275, C:S.275, C:S.276, D:H.466, D:Q.469, D:Q.469
- Salt bridges: C:R.253
- pi-Stacking: C:Y.282
- pi-Cation interactions: C:R.253
NAD.17: 21 residues within 4Å:- Chain A: I.45, A.46, H.466, Q.469
- Chain D: H.93, T.252, R.253, E.254, D.274, S.275, S.276, Q.277, Y.282, N.303, R.322, M.325, G.326, T.333, M.414, Q.441
- Ligands: IMP.18
14 PLIP interactions:11 interactions with chain D, 3 interactions with chain A- Hydrogen bonds: D:H.93, D:T.252, D:R.253, D:R.253, D:E.254, D:S.276, D:S.276, D:T.333, A:A.46, A:Q.469, A:Q.469
- Salt bridges: D:R.253
- pi-Stacking: D:Y.282
- pi-Cation interactions: D:R.253
NAD.22: 21 residues within 4Å:- Chain E: H.93, T.252, R.253, E.254, D.274, S.275, S.276, Q.277, Y.282, N.303, R.322, M.325, G.326, T.333, M.414, Q.441
- Chain F: I.45, A.46, H.466, Q.469
- Ligands: IMP.23
12 PLIP interactions:9 interactions with chain E, 3 interactions with chain F- Hydrogen bonds: E:H.93, E:T.252, E:R.253, E:S.276, E:S.276, E:T.333, F:H.466, F:Q.469, F:Q.469
- Salt bridges: E:R.253
- pi-Stacking: E:Y.282
- pi-Cation interactions: E:R.253
NAD.27: 20 residues within 4Å:- Chain F: H.93, T.252, R.253, E.254, D.274, S.275, S.276, Q.277, Y.282, R.322, M.325, G.326, T.333, M.414, Q.441
- Chain G: I.45, A.46, H.466, Q.469
- Ligands: IMP.28
12 PLIP interactions:3 interactions with chain G, 9 interactions with chain F- Hydrogen bonds: G:H.466, G:Q.469, G:Q.469, F:H.93, F:T.252, F:R.253, F:S.276, F:S.276, F:T.333
- Salt bridges: F:R.253
- pi-Stacking: F:Y.282
- pi-Cation interactions: F:R.253
NAD.32: 21 residues within 4Å:- Chain G: H.93, T.252, R.253, E.254, D.274, S.275, S.276, Q.277, Y.282, R.322, M.325, G.326, T.333, M.414, Q.441
- Chain H: I.42, I.45, A.46, H.466, Q.469
- Ligands: IMP.33
15 PLIP interactions:2 interactions with chain H, 13 interactions with chain G- Hydrogen bonds: H:Q.469, H:Q.469, G:H.93, G:T.252, G:R.253, G:R.253, G:E.254, G:S.275, G:S.276, G:S.276, G:T.333
- Salt bridges: G:R.253
- pi-Stacking: G:Y.282
- pi-Cation interactions: G:R.253, G:R.253
NAD.37: 21 residues within 4Å:- Chain E: I.45, A.46, H.466, Q.469
- Chain H: H.93, T.252, R.253, E.254, D.274, S.275, S.276, Q.277, Y.282, N.303, R.322, M.325, G.326, T.333, M.414, Q.441
- Ligands: IMP.38
14 PLIP interactions:11 interactions with chain H, 3 interactions with chain E- Hydrogen bonds: H:H.93, H:T.252, H:R.253, H:R.253, H:E.254, H:S.276, H:S.276, H:T.333, E:A.46, E:Q.469, E:Q.469
- Salt bridges: H:R.253
- pi-Stacking: H:Y.282
- pi-Cation interactions: H:R.253
- 8 x IMP: INOSINIC ACID(Non-covalent)
IMP.3: 25 residues within 4Å:- Chain A: S.68, P.69, M.70, N.303, R.322, C.327, G.328, S.329, I.330, C.331, I.332, T.333, D.364, G.365, G.366, I.367, M.385, G.387, S.388, Y.411, M.414, G.415, Q.441, G.442
- Ligands: NAD.2
12 PLIP interactions:12 interactions with chain A- Hydrogen bonds: A:S.68, A:S.329, A:I.330, A:D.364, A:D.364, A:G.366, A:I.367, A:G.387, A:S.388, A:S.388, A:S.388, A:Y.411
IMP.8: 24 residues within 4Å:- Chain B: S.68, P.69, M.70, N.303, G.328, S.329, I.330, C.331, I.332, T.333, D.364, G.365, G.366, I.367, M.385, G.387, S.388, Y.411, G.413, M.414, G.415, Q.441, G.442
- Ligands: NAD.7
12 PLIP interactions:12 interactions with chain B- Hydrogen bonds: B:S.68, B:S.329, B:D.364, B:D.364, B:G.366, B:I.367, B:G.387, B:S.388, B:Y.411, B:M.414, B:G.415, B:Q.441
IMP.13: 25 residues within 4Å:- Chain C: S.68, M.70, N.303, G.328, S.329, I.330, C.331, I.332, T.333, D.364, G.365, G.366, I.367, M.385, M.386, G.387, S.388, L.389, Y.411, G.413, M.414, G.415, Q.441, G.442
- Ligands: NAD.12
14 PLIP interactions:14 interactions with chain C- Hydrogen bonds: C:S.68, C:S.329, C:D.364, C:D.364, C:G.366, C:I.367, C:G.387, C:S.388, C:S.388, C:S.388, C:Y.411, C:M.414, C:G.415, C:Q.441
IMP.18: 25 residues within 4Å:- Chain D: S.68, M.70, N.303, G.328, S.329, I.330, C.331, I.332, T.333, D.364, G.365, G.366, I.367, M.385, M.386, G.387, S.388, L.389, Y.411, G.413, M.414, G.415, Q.441, G.442
- Ligands: NAD.17
12 PLIP interactions:12 interactions with chain D- Hydrogen bonds: D:S.68, D:S.329, D:D.364, D:D.364, D:G.366, D:I.367, D:G.387, D:S.388, D:Y.411, D:M.414, D:G.415, D:Q.441
IMP.23: 24 residues within 4Å:- Chain E: S.68, P.69, M.70, N.303, G.328, S.329, I.330, C.331, I.332, T.333, D.364, G.365, G.366, I.367, M.385, G.387, S.388, Y.411, G.413, M.414, G.415, Q.441, G.442
- Ligands: NAD.22
14 PLIP interactions:14 interactions with chain E- Hydrogen bonds: E:S.68, E:N.303, E:S.329, E:I.330, E:D.364, E:D.364, E:G.366, E:I.367, E:G.387, E:S.388, E:Y.411, E:M.414, E:G.415, E:Q.441
IMP.28: 25 residues within 4Å:- Chain F: S.68, P.69, M.70, N.303, G.328, S.329, I.330, C.331, I.332, T.333, D.364, G.365, G.366, I.367, M.385, M.386, G.387, S.388, Y.411, G.413, M.414, G.415, Q.441, G.442
- Ligands: NAD.27
13 PLIP interactions:13 interactions with chain F- Hydrogen bonds: F:S.68, F:S.329, F:I.330, F:D.364, F:D.364, F:G.366, F:I.367, F:G.387, F:S.388, F:Y.411, F:M.414, F:G.415, F:Q.441
IMP.33: 24 residues within 4Å:- Chain G: S.68, M.70, N.303, G.328, S.329, I.330, C.331, I.332, T.333, D.364, G.365, G.366, I.367, M.385, G.387, S.388, L.389, Y.411, G.413, M.414, G.415, Q.441, G.442
- Ligands: NAD.32
13 PLIP interactions:13 interactions with chain G- Hydrogen bonds: G:S.68, G:S.329, G:D.364, G:D.364, G:G.366, G:I.367, G:G.387, G:S.388, G:S.388, G:Y.411, G:M.414, G:G.415, G:Q.441
IMP.38: 23 residues within 4Å:- Chain H: S.68, M.70, N.303, G.328, S.329, I.330, C.331, I.332, T.333, D.364, G.365, G.366, I.367, M.385, G.387, S.388, Y.411, G.413, M.414, G.415, Q.441, G.442
- Ligands: NAD.37
12 PLIP interactions:12 interactions with chain H- Hydrogen bonds: H:S.68, H:S.329, H:I.330, H:D.364, H:D.364, H:G.366, H:I.367, H:S.388, H:Y.411, H:M.414, H:G.415, H:Q.441
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.4: 19 residues within 4Å:- Chain A: I.157, V.158, T.159, S.160, R.161, D.162, T.180, E.184, L.185, V.186, K.206, G.207, K.208, L.209, P.210
- Chain H: R.161, K.205, K.228
- Ligands: GTP.5
16 PLIP interactions:13 interactions with chain A, 3 interactions with chain H- Hydrogen bonds: A:T.159, A:D.162, A:D.162, A:V.186, A:V.186, A:G.207, A:K.208, H:R.161
- Salt bridges: A:R.161, A:R.161, A:R.161, A:K.208, A:K.208, A:K.208, H:R.161, H:K.228
ATP.9: 19 residues within 4Å:- Chain B: I.157, V.158, T.159, S.160, R.161, D.162, T.180, E.184, L.185, V.186, K.206, G.207, K.208, L.209, P.210
- Chain G: R.161, K.205, K.228
- Ligands: GTP.10
14 PLIP interactions:3 interactions with chain G, 11 interactions with chain B- Salt bridges: G:R.161, G:R.161, G:K.228, B:R.161, B:R.161, B:R.161
- Hydrogen bonds: B:T.159, B:T.159, B:D.162, B:D.162, B:V.186, B:V.186, B:G.207, B:K.208
ATP.14: 17 residues within 4Å:- Chain C: I.157, V.158, T.159, S.160, R.161, D.162, T.180, L.185, V.186, K.206, G.207, K.208, L.209, P.210
- Chain F: R.161, K.205
- Ligands: GTP.15
14 PLIP interactions:11 interactions with chain C, 3 interactions with chain F- Hydrogen bonds: C:T.159, C:T.159, C:D.162, C:D.162, C:G.207, C:K.208, C:K.208
- Salt bridges: C:R.161, C:R.161, C:R.161, C:K.208, F:R.161, F:R.161, F:K.228
ATP.19: 18 residues within 4Å:- Chain D: I.157, T.159, S.160, R.161, D.162, T.180, L.185, V.186, K.206, G.207, K.208, L.209, P.210
- Chain E: R.161, K.205, K.206, K.228
- Ligands: GTP.20
9 PLIP interactions:7 interactions with chain D, 2 interactions with chain E- Hydrogen bonds: D:T.159, D:S.160, D:D.162, D:V.186, D:V.186
- Salt bridges: D:R.161, D:R.161, E:R.161, E:K.228
ATP.24: 18 residues within 4Å:- Chain D: R.161, K.205, K.206, K.228
- Chain E: I.157, T.159, S.160, R.161, D.162, T.180, L.185, V.186, K.206, G.207, K.208, L.209, P.210
- Ligands: GTP.25
9 PLIP interactions:2 interactions with chain D, 7 interactions with chain E- Salt bridges: D:R.161, D:K.228, E:R.161, E:R.161
- Hydrogen bonds: E:T.159, E:D.162, E:V.186, E:V.186, E:G.207
ATP.29: 18 residues within 4Å:- Chain C: R.161, K.205, K.228
- Chain F: I.157, T.159, S.160, R.161, D.162, T.180, E.184, L.185, V.186, K.206, G.207, K.208, L.209, P.210
- Ligands: GTP.30
13 PLIP interactions:10 interactions with chain F, 3 interactions with chain C- Hydrogen bonds: F:T.159, F:S.160, F:D.162, F:D.162, F:V.186, F:V.186, F:G.207, F:K.208, C:R.161
- Salt bridges: F:R.161, F:R.161, C:R.161, C:K.228
ATP.34: 18 residues within 4Å:- Chain B: R.161, K.205, K.228
- Chain G: I.157, T.159, S.160, R.161, D.162, T.180, E.184, L.185, V.186, K.206, G.207, K.208, L.209, P.210
- Ligands: GTP.35
12 PLIP interactions:9 interactions with chain G, 3 interactions with chain B- Hydrogen bonds: G:T.159, G:D.162, G:D.162, G:V.186, G:G.207, G:K.208, G:K.208, B:R.161
- Salt bridges: G:R.161, G:R.161, B:R.161, B:K.228
ATP.39: 19 residues within 4Å:- Chain A: R.161, K.205, K.228
- Chain H: I.157, V.158, T.159, S.160, R.161, D.162, T.180, E.184, L.185, V.186, K.206, G.207, K.208, L.209, P.210
- Ligands: GTP.40
13 PLIP interactions:10 interactions with chain H, 3 interactions with chain A- Hydrogen bonds: H:T.159, H:D.162, H:D.162, H:V.186, H:G.207, H:K.208, H:K.208, A:R.161
- Salt bridges: H:R.161, H:R.161, H:R.161, A:R.161, A:K.228
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Burrell, A.L. et al., IMPDH1 retinal variants control filament architecture to tune allosteric regulation. Nat.Struct.Mol.Biol. (2022)
- Release Date
- 2022-01-12
- Peptides
- Inosine-5'-monophosphate dehydrogenase 1: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-octamer
- Ligands
- 16 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 8 x IMP: INOSINIC ACID(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Burrell, A.L. et al., IMPDH1 retinal variants control filament architecture to tune allosteric regulation. Nat.Struct.Mol.Biol. (2022)
- Release Date
- 2022-01-12
- Peptides
- Inosine-5'-monophosphate dehydrogenase 1: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H